ReviewFrontiers in endocrinology2024

Targeting the FSH/FSHR axis in ovarian cancer: advanced treatment using nanotechnology and immunotherapy.

Fuqing Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.